Find a Doctor Medical Traveler Guide Make an Appointment Talk to Doctor

ASST.PROF.DR. NAPA PARINYANITIKUL

Departments

Specialty

Educations

2009

Graduate Certificate of Medical Oncology The Royal College of Physicians of Thailand
Graduate Master’s degree of Science Faculty of Medicine, Chulalongkorn University.

2007

Graduate Certificate of Internal Medicine The Royal College of Physicians of Thailand

2005

Graduate Diplomas of Clinical Sciences Faculty of Medicine, Chulalongkorn University

2001

Doctor of Medicine (1st class Honours) Faculty of Medicine, Chulalongkorn University

Fellowships

Instructor and Associated professor in Medical Oncology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

2014

Postdoctoral Fellowship training in Breast Medical Oncology Department MD Anderson Cancer Canter, Houston,Texas, USA Medical Oncology Fellowship

2009

Medical Oncology Fellowship King Chulalongkorn Memorial Hospital, Bangkok, Thailand Internal Medicine Resident

2007

Internal Medical Residence King Chulalongkorn Memorial Hospital, Bangkok, Thailand

2004

General Practitioner Khaokitchakood community Hospital Chanthaburi, Thailand

2002

Medical Internship: Complete Rotation Prapokklao Chanthaburi Provincial Hospital Chanthaburi, Thailand

Publications

2022

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy. JCO Precis Oncol. 2022 Mar;6:e2000368. doi:10.1200/PO.20.00368.
Hiroko Masuda H, Kenichi Harano K, Mira S, Wang Y, Yuko Hirota, Harada O, et al.Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Maior Asian Territories. J Breast Cancer. 2022 Jun;25(3):e21 Ithimaki S, Parinyanitikul N, Kim SB, Yap YS, Tsan J, et al.

2021

Autoimmune hemolytic anemia, rare immune-related adverse event after the combination of atezolizumab and paclitaxel treatment in recurrent triple-negative breast cancer: A case report. J Med Case Rep Case Series 2021.
Sintawichai N. Lawasut P, Poovorawan N. Parinyanitikul N.: Case report What is the best systemic treatment for newly diagnosed inflammatory breast cancer? A narrative review. Chin Clin Onco 2021 Oct 19;Cco-21-81.
Chainitikun S, Mingmalairak S, Parinyanitikul N.: Review Article Lactic acidosis, potential toxicity from drug-drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report. Cancer Rep (Hoboken) 2021 Nov 5;e15 75. doi: 10.1002 / cnr2.1575 Lagampan C, Poovorawan N, Parinyanitikul N.: Case report

2020

Siripanya S, Parinyanitikul N, Tanaka H, Suksom D.: Original Article The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Int J Clin Oncol.2020;25(2):396-402.
Vimolchalao V, Sakdejayont S, Longchamp P, Sukprakun S, Angspatt P, Thawinwisan W,Chenaksara P, Sriuranpong V, Vinayanuwattikun C, Parinyanitikul N, Poovorawan N, Tanasanvimol S. : Original Article

2019

Prevalence of Retinoblastoma Protein Loss by Immunohistochemistry in Triple-Negative Breast Cancer. J Med Assoc Thai 2019; 102(1): 19-27.
Napa Parinyanitikul, Prakongboon Sungkasubun, Voranuch Tanakit, Virote riuranpon :Original Article
Tumor mutational profile of triple-negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodelling gene. PeerJ 2019.
Suvimol Niyomnaitham, Napa Parinyanitikul, Ekkapong Roothumnong, Worapoj Jinda, Norasate Samarnthai, Taywin Atikankul, Bhoom Suktitipat, Wanna Thongnoppakhun, Chain Limwongse, Manop Pithukpakorn.: Original Article
Vascular Dysfunction in Breast Cancer Patients Receiving Anthracycline Chemotherapy: A Cross-Sectional Study. J Med Assoc Thai 2019; 102(5): 554-9.

2018

Incidence of an infusion hypersensitivity reaction after withholding dexamethasone Premedication in early breast cancer patients not experiencing two previous cycles of infusion hypersensitivity. Supportive Care in Cancer July 2018, Vol.26, No.7; 2471-2477.
Napa Parinyanitikul, Walailuk Tanpipattanakul, Nattaya Poovorawan, Thanapoom Rattananupong, Poranee Laoitthi, Piyada Sithidetphaiboon, Suebpong Thanasanvimon, Virote Sriuranpong. : Original Article
Cooperative effect of oncogenic MET and PIK3CA in an HGF-dominant environment in breast cancer. Mol Can Ther. Published Online First December 5. 2018.
Shuying Liu, Shunqiang Li, Bailing Wang, Wenbin Liu, Mihai Gagea, Huiqin Chen, Joohyuk Sohn, Napa Parinyanitikul, Tina Primeau, Kim-Anh Do, George F Vande Woude, John Mendelsohn, Naoto T. Ueno, Gordon B. Mills, Debu Tripathy, and Ana M.Gonzalez-Angulo. : Original Article

2017

Triple-Negative Breast Cancer in Thai Patients: Experience in King Chulalongkorn Memorial Hospital. Chula Med J vol.61, No.5 September-October 2017
Napa Parinyanitikul, Voranuch Tanakit, Caroline Miranda, Poranee Laoitthi, Sopark Manasnayakorn, Tassapong Raiyawa, Virote Sriuranpong. : Original Article

Show more Publications

Professional Membership

2009

Member, Thai society of clinical oncology

2007

Member, of the Royal College of Physicians of Thailand

2001

Member, the Medical Council of Thailand

Extracurricular Activities

2003

Head of Hospital Accreditation Program and vice director at Khaokitchakood Community Hospital.

1999

Vice Director of Medicine Team and Head of Physiology Team: Chulalongkorn University Academic Exhibition.

1996

Head of Physiology Team: Chulalongkorn University Academic Exhibition Vice Director: Photo camp at Doi Inthanon, Photo Club, Chulalongkorn University

Clinic Hours